Outcome of bronchial artery embolisation for life threatening haemoptysis due to tuberculosis and post tuberculosis sequelae.

Bronchial artery embolization in hemoptysis: a systematic review

“…In fact, a few studies reported the role of BAE exclusively in patients with active TB and/or post-TB sequelae (9,18,21,25,27). On the other hand, malignancies, nontubercular mycobacterial infections, lung abscesses, vasculitis, and cryptogenic hemoptysis were Bronchial artery embolization in hemoptysis • 309 more common in studies published from Western population (8,12).…”

“…While some authors have used "major", "severe", and "massive" terms interchangeably, others specifically considered massive hemoptysis as life threatening. Furthermore, some authors emphasized that even a small volume of hemoptysis could flood the airspaces in diseased lungs, cause asphyxiation and thus be potentially life-threatening (27). Few studies, instead of grading severity of hemoptysis, described whether BAE was performed in acute massive hemoptysis under emergent conditions or was performed electively for chronic recurrent hemoptysis (13,22).…”

“…We also excluded five studies whose full-texts were not available despite our best efforts. Finally, there were 22 studies (5)(6)(7)(8)(9)(10)(11)(12)(13)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27) meeting the selection criteria for this systematic review. The search strategy is schematized in Fig.…”

Bronchial Artery Embolization in Hemoptysis: 10-Year Survival and Recurrence-Free Survival in Benign and Malignant Etiologies – A Retrospective Study

“…However, no benign underlying disease could be identified as having the most unfavorable outcome with respect to recurrent bleeding because of the small sample size of recurrence in the benign subgroup (1 chronic heart failure, 2 vascular malformations, 2 aspergillomas, and 1 status post tuberculosis). Other studies report a control rate of 51 % at 1 year and 38.7 % at 2 years in tuberculosis [12] or a recurrence rate of up to 100 % in patients with aspergillomas [4]. The median time to recurrence was 239 days in the benign group and 66 days in the malignant group.…”

Diagnosis and management of hemoptysis

“…Aside from the immediate control of bleeding, Anuradha et al (52) recently demonstrated that in patients with massive hemoptysis due to tuberculosis and post-tuberculous sequelae, the effectiveness of BAE tends to decrease over years, being 51% in the first year and 39% in the second year after treatment. Nevertheless, repeated BAE in patients with early recurrence improves the outcome.…”